Ubs Group Ag ALDER BIOPHARMACEUTICALS INC Transaction History

Ubs Group Ag

  • $452 Billion
  • Q3 2024

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 14, 2020
SELL
N/A
-221,597 Closed
0 $0
Q3 2019

Nov 14, 2019
BUY
N/A
171,442 Added 341.82%
221,597 $4.18 Million
Q2 2019

Aug 14, 2019
SELL
N/A
-71,682 Reduced 58.83%
50,155 $591,000
Q1 2019

May 14, 2019
BUY
N/A
20,005 Added 19.65%
121,837 $1.66 Million
Q4 2018

Feb 14, 2019
BUY
N/A
81,456 Added 399.76%
101,832 $1.04 Million
Q3 2018

Nov 14, 2018
BUY
N/A
17,288 Added 559.84%
20,376 $339,000
Q2 2018

Aug 14, 2018
SELL
N/A
-225,749 Reduced 98.65%
3,088 $49,000
Q1 2018

May 15, 2018
BUY
N/A
212,303 Added 1284.04%
228,837 $2.91 Million
Q4 2017

Feb 14, 2018
SELL
N/A
-60,476 Reduced 78.53%
16,534 $189,000
Q3 2017

Nov 14, 2017
BUY
N/A
76,003 Added 7547.47%
77,010 $943,000
Q2 2017

Aug 14, 2017
SELL
N/A
-610 Reduced 37.72%
1,007 $12,000
Q1 2017

Nov 14, 2017
BUY
N/A
1,617
1,617 $33,000
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email